Johnson Pharmacare Ltd Financials
Company Logo

Johnson Pharmacare Ltd Financial Statement

Johnson Pharmacare Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
RevenueTBA
Operating ExpenseTBA
Net ProfitTBA
Net Profit MarginTBA
Earning Per ShareTBA
EBIDTATBA
Effective Tax RateTBA

Johnson Pharmacare Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue AnnualTBA
Operating Expenses Annual0.20
Operating Profit Annual-0.20
Interest AnnualTBA
DepreciationTBA
Net Profit Annual-0.20
Tax AnnualTBA

Johnson Pharmacare Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the BeginningTBA
Cash Flow from Operations-0.05
Cash Flow from InvestingTBA
Cash Flow from Financing0.05
Cash Flow at the EndTBA

Johnson Pharmacare Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)TBA
PBIT Margin (%)TBA
PBT Margin (%)TBA
Net PROFIT Margin (%)TBA
Return On Networth / Equity (%)TBA
Return On Networth /Employed (%)TBA
Return On Assets (%)TBA
Total Debt / Equity (X)0.03
Asset Turnover Ratio (%)TBA

Johnson Pharmacare Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets AnnualTBA
Total Current Assets Annual0.00
Non Current Assets Annual59.83
Total Shareholders Funds Annual56.75
Total Assets Annual59.83

Johnson Pharmacare Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Dec 9, 2024, Johnson Pharmacare Ltd has a market capitalization of 37.95 Cr. Value Research classifies it as a Micro-Cap company.
Yes, Johnson Pharmacare Ltd is debt-free with a debt-to-equity ratio of 0.03.
In FY 2023 , Johnson Pharmacare Ltd recorded a total revenue of approximately 0 Cr marking a significant milestone in the company's financial performance.
Johnson Pharmacare Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.3% and -100.0% annually, respectively..
Johnson Pharmacare Ltd's current PE ratio is -189.75.
Johnson Pharmacare Ltd's ROCE averaged -0.8% from the FY ending March 2022 to 2024, with a median of -0.3%. It peaked at 0.2% in March 2022, reflecting strong capital efficiency over the period..
Johnson Pharmacare Ltd's latest EBIT is Rs. -0.20 Cr, surpassing the average EBIT of Rs. -0.45 Cr over the 5 years..
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions